| |
| |
|
| Insider
Information: |
Gould Robert J |
| Relationship: |
Interim President & CE... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
499,864 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
499,864 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
Director |
2015-12-30 |
0 |
2014-01-02 |
0 |
Premium* |
|
|
Fulcrum Therapeutics, Inc. |
FULC |
Interim President & CE... |
2023-01-13 |
499,864 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2015-09-08 |
4 |
OE |
$0.51 |
$30,600 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2015-12-29 |
4 |
OE |
$0.51 |
$10,355 |
D/D |
20,303 |
20,303 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2015-12-29 |
4 |
AS |
$18.01 |
$365,618 |
D/D |
(20,303) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2015-12-30 |
4 |
OE |
$0.51 |
$6,021 |
D/D |
11,805 |
11,805 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2015-12-30 |
4 |
AS |
$18.02 |
$212,713 |
D/D |
(11,805) |
0 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See RemarksOfficer |
• • • |
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
557,345 |
|
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-02-19 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
554,845 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-05-26 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
552,345 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-05-28 |
4 |
AS |
$20.01 |
$38,391 |
D/D |
(1,919) |
550,426 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-05-29 |
4 |
AS |
$20.08 |
$27,911 |
D/D |
(1,390) |
549,036 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-01 |
4 |
AS |
$20.00 |
$100 |
D/D |
(5) |
549,031 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-02 |
4 |
AS |
$20.00 |
$55,940 |
D/D |
(2,797) |
546,234 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-03 |
4 |
AS |
$20.13 |
$30,192 |
D/D |
(1,500) |
544,734 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-04 |
4 |
AS |
$20.04 |
$26,058 |
D/D |
(1,300) |
543,434 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-05 |
4 |
AS |
$20.17 |
$69,251 |
D/D |
(3,433) |
540,001 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-09 |
4 |
AS |
$20.00 |
$3,120 |
D/D |
(156) |
539,845 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-06-25 |
4 |
AS |
$20.80 |
$51,992 |
D/D |
(2,500) |
537,345 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2020-07-08 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
534,845 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2021-01-20 |
4 |
AS |
$12.08 |
$120,826 |
D/D |
(10,000) |
524,845 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2021-02-16 |
4 |
AS |
$14.19 |
$117,197 |
D/D |
(8,215) |
516,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2021-03-15 |
4 |
AS |
$12.13 |
$111,773 |
D/D |
(9,211) |
507,419 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
See Remarks |
• • – |
2021-03-16 |
4 |
AS |
$12.43 |
$9,806 |
D/D |
(789) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-01 |
4 |
AS |
$24.03 |
$828,160 |
D/D |
(34,464) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-01 |
4 |
OE |
$7.84 |
$270,198 |
D/D |
34,464 |
541,094 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-04 |
4 |
OE |
$7.84 |
$56,722 |
D/D |
7,235 |
513,865 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
